New study uncovers how gliomas disrupt brain function and points to rapid therapeutic reversal
A study led by Dr. Peter Canoll's lab, in collaboration with researchers at Columbia University Irving Medical Center, ...
Nature9y
Seeing mTOR in a new light
Although the mTOR pathway has been characterized in T cells, it has not been well described in other immune cells. In this study, Weichhart et al. investigated how mTOR activity in phagocytes ...
technologynetworks2d
Study Uncovers How Gliomas Disrupt Brain Function
A Columbia-led study uncovers how gliomas cause seizures and cognitive impairments by disrupting brain activity. Using ...
Science Daily21d
Scientists uncover rapid-acting, low-side-effect antidepressant target
The mechanistic (or mammalian) target of rapamycin (mTOR) signaling pathway, implicated in rapid antidepressant effects, was investigated for its role in KNT-127's action. The researchers injected ...
Aromatic plant can fight colorectal cancer, say scientists
Scientists from the University of Sharjah have found that a naturally growing aromatic plant contains ingredients with the ...
Hosted on MSN1mon
'Smooth brain' disorders may share a common cause—and a potential treatment
Their findings pointed to dysregulation in the mTOR (mammalian target of rapamycin) pathway in both types of lissencephaly organoids they were studying. "This is a fundamental pathway that governs ...
Neurizon granted US patent for lead drug to treat motor neurone and other neurodegenerative conditions
Neurizon Therapeutics has achieved a key milestone with a patent granted in the US for its lead drug candidate NUZ-001 to ...